Risk of fracture in urolithiasis: A population-based cohort study using the health improvement network

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 12, 2014, Pages 2133-2140

  Denburg, Michelle R ^a   Leonard, Mary B ^a   Haynes, Kevin ^b   Tuchman, Shamir ^c   Tasian, Gregory ^a   Shults, Justine ^a   Copelovitch, Lawrence ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Center for Clinical Epidemiology and Biostatistics   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LOOP DIURETIC AGENT;

ADOLESCENCE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FRACTURE; GOUT; HUMAN; IMMOBILITY; INCIDENCE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROGENIC BLADDER; PREMATURITY; PRIMARY HYPERPARATHYROIDISM; RETROSPECTIVE STUDY; RISK ASSESSMENT; UROLITHIASIS; VERY ELDERLY; YOUNG ADULT; AGE; CASE CONTROL STUDY; FRACTURES, BONE; RISK FACTOR; SEX DIFFERENCE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; FEMALE; FRACTURES, BONE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; UROLITHIASIS; YOUNG ADULT;

EID: 84923821592     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04340514     Document Type: Article

References (38)

1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC: Time trends in reported prevalence of kidney stones in theUnited States: 1976-1994. Kidney Int 63: 1817–1823, 2003
2. Worcester EM, Coe FL: Clinical practice. Calciumkidney stones. N Engl J Med 363: 954–963, 2010
3. Eisner BH, Porten SP, Bechis SK, Stoller ML: Diabetic kidney stone formers excretemore oxalate and have lower urine pHthan nondiabetic stone formers. J Urol 183: 2244–2248, 2010
4. Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain, and the risk of kidney stones. JAMA 293: 455–462, 2005
5. Coe FL, Keck J, Norton ER: The natural history of calcium urolithiasis. JAMA 238: 1519–1523, 1977
6. Eisner BH, Sheth S, Dretler SP, Herrick B, Pais VM Jr: Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers. Urology 80: 776–779, 2012
7. Hodgkinson A, Pyrah LN: The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg 46: 10–18, 1958
8. Pietschmann F, Breslau NA, Pak CY: Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7: 1383–1388, 1992
9. Cauley JA, Fullman RL, Stone KL, Zmuda JM, Bauer DC, Barrett-Connor E, Ensrud K, Lau EM, Orwoll ES; Mr. OS Research Group: Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int 16: 1525–1537, 2005
10. Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C: Low bone mass in idiopathic renal stone formers: Magnitude and significance. J Bone Miner Res 9: 1525–1532, 1994
11. Lawoyin S, Sismilich S, Browne R, Pak CY: Bone mineral content in patients with calcium urolithiasis. Metabolism 28: 1250–1254, 1979
12. Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson B: Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures. Am J Epidemiol 147: 914–920, 1998
13. Bataille P, Fardellone P, Ghazali A, Cayrolle G, Hottelart C, Achard JM, Fournier A: Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol 10: 373–388, 1998
14. Fuss M, Pepersack T, Van Geel J, Corvilain J, Vandewalle JC, Bergmann P, Simon J: Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers. Calcif Tissue Int 46: 9–13, 1990
15. Lauderdale DS, Thisted RA, Wen M, Favus MJ: Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 16: 1893–1898, 2001
16. Weisinger JR, Alonzo E, Bellorın-Font E, Blasini AM, Rodriguez MA, Paz-Martınez V, Martinis R: Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49: 244–250, 1996
17. Asplin JR, Bauer KA, Kinder J, Muller G, Coe BJ, Parks JH, Coe FL: Bonemineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 63: 662–669, 2003
18. Melton LJ 3rd, Crowson CS, Khosla S, Wilson DM, O’Fallon WM: Fracture risk among patients with urolithiasis: A populationbased cohort study. Kidney Int 53: 459–464, 1998
19. Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y: Diuretic initiation and the acute risk of hip fracture. Osteoporos Int 24: 689–695, 2013
20. Collins GS, Mallett S, Altman DG: Predicting risk of osteoporotic and hip fracture in the United Kingdom: Prospective independent and external validation of QFractureScores. BMJ 342: d3651, 2011
21. Gutiérrez L, Roskell N, Castellsague J, Beard S, Rycroft C, Abeysinghe S, Shannon P, Gitlin M, Robbins S: Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom. Bone 51: 324–331, 2012
22. Gutiérrez L, Roskell N, Castellsague J, Beard S, Rycroft C, Abeysinghe S, Shannon P, Robbins S, Gitlin M: Study of the incremental cost and clinical burden of hip fractures in postmenopausal women in the United Kingdom. J Med Econ 14: 99–107, 2011
23. Orton E, Kendrick D, West J, Tata LJ: Independent risk factors for injury in pre-school children: Three population-based nested case-control studies using routine primary care data. PLoS ONE 7: e35193, 2012
24. Pujades-Rodríguez M, Smith CJ, Hubbard RB: Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease. QJM 100: 509–517, 2007
25. Schelleman H, Pollard JR, Newcomb C, Markowitz CE, Bilker WB, Leonard MB, Hennessy S: Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures. Pharmacoepidemiol Drug Saf 20: 619–625, 2011
26. van Staa TP, Kanis JA, Geusens P, Boonen A, Leufkens HG, Cooper C: The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks. Value Health 10: 348–357, 2007
27. Finkelstein JS, Lee ML, Sowers M, Ettinger B, Neer RM, Kelsey JL, Cauley JA, Huang MH, Greendale GA: Ethnic variation in bone density in premenopausal and early perimenopausal women: Effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab 87: 3057–3067, 2002
28. Chisholm J: The Read clinical classification. BMJ 300: 1092, 1990
29. Lewis JD, Bilker WB, Weinstein RB, Strom BL: The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 14: 443–451, 2005
30. Blak BT, Thompson M, Dattani H, Bourke A: Generalisability of The Health Improvement Network (THIN) database: Demographics, chronic disease prevalence and mortality rates. Inform Prim Care 19: 251–255, 2011
31. García-Nieto V, Ferrández C, Monge M, de Sequera M, Rodrigo MD: Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr Nephrol 11: 578–583, 1997
32. Penido MG, Lima EM, Marino VS, Tupinambá AL, Franca A, Souto MF: Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis. Pediatr Nephrol 18: 133–139, 2003
33. Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G, Minicuci N, Crepaldi G: Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 149: 209–213, 2003
34. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M: Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87: 4431–4437, 2002
35. LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, George LK, Cornoni-Huntley J, Ostfeld AM: Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 322: 286–290, 1990
36. LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE: Lowdose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebocontrolled trial. Ann Intern Med 133: 516–526, 2000
37. Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, Murray MA, McNeil AR, Gamble GD: Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: A randomized controlled trial. Am JMed 109: 362–370, 2000
38. Jehle S, Zanetti A, Muser J, Hulter HN, Krapf R: Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia. J Am Soc Nephrol 17: 3213–3222, 2006